Uncovering the trimethylamine-producing bacteria of the human gut microbiota.

Rath, Silke; Heidrich, Benjamin; Pieper, Dietmar H; Vital, Marius

dc.contributor.author	Rath, Silke
dc.contributor.author	Heidrich, Benjamin
dc.contributor.author	Pieper, Dietmar H
dc.contributor.author	Vital, Marius
dc.date.accessioned	2017-06-14T20:09:01Z
dc.date.available	2017-06-14T20:09:01Z
dc.date.issued	2017-05-15
dc.identifier.citation	Uncovering the trimethylamine-producing bacteria of the human gut microbiota. 2017, 5 (1):54 Microbiome	en
dc.identifier.issn	2049-2618
dc.identifier.pmid	28506279
dc.identifier.doi	10.1186/s40168-017-0271-9
dc.identifier.uri	http://hdl.handle.net/10033/620945
dc.description.abstract	Trimethylamine (TMA), produced by the gut microbiota from dietary quaternary amines (mainly choline and carnitine), is associated with atherosclerosis and severe cardiovascular disease. Currently, little information on the composition of TMA producers in the gut is available due to their low abundance and the requirement of specific functional-based detection methods as many taxa show disparate abilities to produce that compound.
dc.language.iso	en	en
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/4.0/	*
dc.title	Uncovering the trimethylamine-producing bacteria of the human gut microbiota.	en
dc.type	Article	en
dc.contributor.department	Helmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.	en
dc.identifier.journal	Microbiome	en
refterms.dateFOA	2018-06-13T04:08:45Z
html.description.abstract	Trimethylamine (TMA), produced by the gut microbiota from dietary quaternary amines (mainly choline and carnitine), is associated with atherosclerosis and severe cardiovascular disease. Currently, little information on the composition of TMA producers in the gut is available due to their low abundance and the requirement of specific functional-based detection methods as many taxa show disparate abilities to produce that compound.